
- Telehealth Visits
- Insurance plan information


Sasha Gupta, MD
Neurology • Neuroimmunology- Telehealth Visits
- Insurance plan information




Sasha Gupta, MD
Neurology • Neuroimmunology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Psychiatry and Neurology
Fellowship
- Neuroimmunology, UCSF Benioff Children's Hosp San Francisco
Residency
- Neurology, UCSF Graduate Medical Education
Internship
- Neurology, UCSF Graduate Medical Education
Degree
- MD, Yale University School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222441%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222441%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 22 reviews
- January 17, 20265 out of 5 Stars
Dr Gupta is awesome and super supportive!
- January 6, 20265 out of 5 Stars
She was professional and friendly and really showed care and concern for my well-being in addition to be deeply knowledgeable
- December 17, 20255 out of 5 Stars
I was treated very professionally.
- October 24, 20255 out of 5 Stars
I have recommended UCSF and its staff to anyone that will listen. I'm in a study there and have seen many specialists with you over the years. Always excellent, friendly, professional, informative. I could not be happier with the care I have received here. Thank you for all that you do.
- October 21, 20255 out of 5 Stars
The care I am given is everything I want and need in a care provider.
- October 7, 20255 out of 5 Stars
I would rate higher if I could
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.